Global Brain Gene Expression Analysis Links Glutamatergic and GABAergic Alterations to Suicide and Major Depression

Background Most studies investigating the neurobiology of depression and suicide have focused on the serotonergic system. While it seems clear that serotonergic alterations play a role in the pathogenesis of these major public health problems, dysfunction in additional neurotransmitter systems and other molecular alterations may also be implicated. Microarray expression studies are excellent screening tools to generate hypotheses about additional molecular processes that may be at play. In this study we investigated brain regions that are known to be implicated in the neurobiology of suicide and major depression are likely to represent valid global molecular alterations. Methodology/Principal Findings We performed gene expression analysis using the HG-U133AB chipset in 17 cortical and subcortical brain regions from suicides with and without major depression and controls. Total mRNA for microarray analysis was obtained from 663 brain samples isolated from 39 male subjects, including 26 suicide cases and 13 controls diagnosed by means of psychological autopsies. Independent brain samples from 34 subjects and animal studies were used to control for the potential confounding effects of comorbidity with alcohol. Using a Gene Ontology analysis as our starting point, we identified molecular pathways that may be involved in depression and suicide, and performed follow-up analyses on these possible targets. Methodology included gene expression measures from microarrays, Gene Score Resampling for global ontological profiling, and semi-quantitative RT-PCR. We observed the highest number of suicide specific alterations in prefrontal cortical areas and hippocampus. Our results revealed alterations of synaptic neurotransmission and intracellular signaling. Among these, Glutamatergic (GLU) and GABAergic related genes were globally altered. Semi-quantitative RT-PCR results investigating expression of GLU and GABA receptor subunit genes were consistent with microarray data. Conclusions/Significance The observed results represent the first overview of global expression changes in brains of suicide victims with and without major depression and suggest a global brain alteration of GLU and GABA receptor subunit genes in these conditions.

[1]  Alexander F. Wilson,et al.  Genetic markers of suicidal ideation emerging during citalopram treatment of major depression. , 2007, The American journal of psychiatry.

[2]  G. Rajkowska,et al.  Gliogenesis and glial pathology in depression. , 2007, CNS & neurological disorders drug targets.

[3]  Gregor Hasler,et al.  Reduced prefrontal glutamate/glutamine and gamma-aminobutyric acid levels in major depression determined using proton magnetic resonance spectroscopy. , 2007, Archives of general psychiatry.

[4]  Paul J Carlson,et al.  A randomized trial of an N-methyl-D-aspartate antagonist in treatment-resistant major depression. , 2006, Archives of general psychiatry.

[5]  Howard J. Edenberg,et al.  Effects of filtering by Present call on analysis of microarray experiments , 2006, BMC Bioinformatics.

[6]  Paul Pavlidis,et al.  ErmineJ: Tool for functional analysis of gene expression data sets , 2005, BMC Bioinformatics.

[7]  R. Myers,et al.  Altered cortical glutamatergic and GABAergic signal transmission with glial involvement in depression , 2005, Proceedings of the National Academy of Sciences of the United States of America.

[8]  Karuturi R. Krishna Murthy,et al.  Bias in the estimation of false discovery rate in microarray studies , 2005, Bioinform..

[9]  Purvesh Khatri,et al.  Ontological analysis of gene expression data: current tools, limitations, and open problems , 2005, Bioinform..

[10]  Yogesh K. Dwivedi,et al.  Brain Region Specific Alterations in the Protein and mRNA Levels of Protein Kinase A Subunits in the Post-Mortem Brain of Teenage Suicide Victims , 2005, Neuropsychopharmacology.

[11]  G. Turecki,et al.  Familial aggregation of suicidal behavior: a family study of male suicide completers from the general population. , 2005, The American journal of psychiatry.

[12]  R. Parsey,et al.  Neuroanatomic correlates of psychopathologic components of major depressive disorder. , 2005, Archives of general psychiatry.

[13]  Fuad G. Gwadry,et al.  Molecular characterization of suicide by microarray analysis , 2005, American journal of medical genetics. Part C, Seminars in medical genetics.

[14]  P. Escribá,et al.  Increased mRNA Expression of α2A-Adrenoceptors, Serotonin Receptors and μ-Opioid Receptors in the Brains of Suicide Victims , 2004, Neuropsychopharmacology.

[15]  S. Siegel,et al.  Neurobiology of Mental Illness , 2004 .

[16]  John H Krystal,et al.  Subtype-specific alterations of gamma-aminobutyric acid and glutamate in patients with major depression. , 2004, Archives of general psychiatry.

[17]  Yogesh K. Dwivedi,et al.  Decreased catalytic activity and expression of protein kinase C isozymes in teenage suicide victims: a postmortem brain study. , 2004, Archives of general psychiatry.

[18]  H. Hermesh,et al.  DRD4 receptor gene exon III polymorphism in inpatient suicidal adolescents , 2004, Journal of Neural Transmission.

[19]  Anthony R. McIntosh,et al.  Limbic–frontal circuitry in major depression: a path modeling metanalysis , 2004, NeuroImage.

[20]  Michael Marriott,et al.  Lower hippocampal volume in patients suffering from depression: a meta-analysis. , 2004, The American journal of psychiatry.

[21]  H. Anisman,et al.  Dysregulation in the Suicide Brain: mRNA Expression of Corticotropin-Releasing Hormone Receptors and GABAA Receptor Subunits in Frontal Cortical Brain Region , 2004, The Journal of Neuroscience.

[22]  Paul Pavlidis,et al.  Gene Expression Profiling of Depression and Suicide in Human Prefrontal Cortex , 2004, Neuropsychopharmacology.

[23]  Yogesh K. Dwivedi,et al.  Protein kinase a in postmortem brain of depressed suicide victims: altered expression of specific regulatory and catalytic subunits , 2004, Biological Psychiatry.

[24]  Dennis S. Charney,et al.  Neurobiology of Mental Illness , 2004 .

[25]  Brad T. Sherman,et al.  DAVID: Database for Annotation, Visualization, and Integrated Discovery , 2003, Genome Biology.

[26]  Y. Sheline.  Neuroimaging studies of mood disorder effects on the brain , 2003, Biological Psychiatry.

[27]  P. Brambilla,et al.  GABAergic dysfunction in mood disorders , 2003, Molecular Psychiatry.

[28]  C. Normann,et al.  Recent advances in the neurobiology of depression , 2003 .

[29]  C. V. Jongeneel,et al.  Comprehensive sampling of gene expression in human cell lines with massively parallel signature sequencing , 2003, Proceedings of the National Academy of Sciences of the United States of America.

[30]  Huda Akil,et al.  Microarray technology: a review of new strategies to discover candidate vulnerability genes in psychiatric disorders. , 2003, The American journal of psychiatry.

[31]  D. Pellegrini-Giampietro.  An activity-dependent spermine-mediated mechanism that modulates glutamate transmission , 2003, Trends in Neurosciences.

[32]  Glenda M MacQueen,et al.  Course of illness, hippocampal function, and hippocampal volume in major depression , 2003, Proceedings of the National Academy of Sciences of the United States of America.

[33]  O. Petroff,et al.  Book Review: GABA and Glutamate in the Human Brain , 2002 .

[34]  Yogesh K. Dwivedi,et al.  mRNA and Protein Expression of Selective Alpha Subunits of G Proteins are Abnormal in Prefrontal Cortex of Suicide Victims , 2002, Neuropsychopharmacology.

[35]  M A Mintun,et al.  The hippocampus and depression , 2002, European Psychiatry.

[36]  P. Dodd,et al.  Spermine modulation of the glutamatenmda receptor is differentially responsive to conantokins in normal and Alzheimer's disease human cerebral cortex , 2002 .

[37]  J. Bergquist,et al.  Suicide-attempters having immunoglobulin G with affinity for dopamine in cerebrospinal fluid , 2002, European Neuropsychopharmacology.

[38]  G F Mason,et al.  Glutamate and GABA systems as targets for novel antidepressant and mood-stabilizing treatments , 2002, Molecular Psychiatry.

[39]  C. Stewart,et al.  Antidepressant mechanisms: functional and molecular correlates of excitatory amino acid neurotransmission , 2002, Molecular Psychiatry.

[40]  Eric Vermetten,et al.  Reduced volume of orbitofrontal cortex in major depression , 2002, Biological Psychiatry.

[41]  G. Turecki.  Suicidal behavior: is there a genetic predisposition? , 2001, Bipolar disorders.

[42]  Julio Frenk,et al.  World Health Report 2000: a step towards evidence-based health policy , 2001, The Lancet.

[43]  Victoria Arango,et al.  The Neurobiology and Genetics of Suicide and Attempted Suicide: A Focus on the Serotonergic System , 2001, Neuropsychopharmacology.

[44]  M. Berk,et al.  Platelet Glutamate Receptor Supersensitivity in Major Depressive Disorder , 2001, Clinical neuropharmacology.

[45]  Yogesh K. Dwivedi,et al.  Reduced activation and expression of ERK1/2 MAP kinase in the post‐mortem brain of depressed suicide subjects , 2001, Journal of neurochemistry.

[46]  W. Drevets,et al.  The cellular neurobiology of depression , 2001, Nature Medicine.

[47]  Alexandra Robbins,et al.  The World Health Report 2000: Health Systems: Improving Performance. Geneva: World Health Organization; 2000. 150 pages plus tables; $13.50; available on-line from: URL: http://www.who.int/whr/ , 2001 .

[48]  J. Lorberbaum,et al.  From the Departments Of , 2022 .

[49]  W. Drevets.  Neuroimaging and neuropathological studies of depression: implications for the cognitive-emotional features of mood disorders , 2001, Current Opinion in Neurobiology.

[50]  Y. Sheline.  3D MRI studies of neuroanatomic changes in unipolar major depression: the role of stress and medical comorbidity , 2000, Biological Psychiatry.

[51]  W. Drevets.  Neuroimaging studies of mood disorders , 2000, Biological Psychiatry.

[52]  D. Charney,et al.  Imaging serotonergic neurotransmission in depression: hippocampal pathophysiology may mirror global brain alterations , 2000, Biological Psychiatry.

[53]  R. Sapolsky,et al.  Glucocorticoids and hippocampal atrophy in neuropsychiatric disorders. , 2000, Archives of general psychiatry.

[54]  U. Reinhardt,et al.  The world health report 2000 - Health systems: improving performance , 2000 .

[55]  M. Ashburner,et al.  Gene Ontology: tool for the unification of biology , 2000, Nature Genetics.

[56]  Bernadette Lipinski,et al.  Reduced glutamate in the anterior cingulate cortex in depression: an in vivo proton magnetic resonance spectroscopy study , 2000, Biological Psychiatry.

[57]  J. Haycock,et al.  Elevated levels of tyrosine hydroxylase in the locus coeruleus in major depression , 1999, Biological Psychiatry.

[58]  Andrei Rozov,et al.  Polyamine-dependent facilitation of postsynaptic AMPA receptors counteracts paired-pulse depression , 1999, Nature.

[59]  H. Samson,et al.  Chronic ethanol self-administration in a continuous-access operant situation: the use of a sucrose/ethanol solution to increase daily ethanol intake. , 1999, Alcohol.

[60]  M. Alda,et al.  Prediction of level of serotonin 2A receptor binding by serotonin receptor 2A genetic variation in postmortem brain samples from subjects who did or did not commit suicide. , 1999, The American journal of psychiatry.

[61]  Abraham Weizman,et al.  The suicide brain: a review of postmortem receptor/transporter binding studies , 1998, Neuroscience & Biobehavioral Reviews.

[62]  G. Ordway,et al.  Pathophysiology of the Locus Coeruleus in Suicide a , 1997, Annals of the New York Academy of Sciences.

[63]  H. Meltzer,et al.  Reduced Levels of Norepinephrine Transporters in the Locus Coeruleus in Major Depression , 1997, The Journal of Neuroscience.

[64]  J. Kleinman,et al.  Glutamate receptors in the postmortem striatum of schizophrenic, suicide, and control brains , 1997, Synapse.

[65]  K. Williams.  Interactions of polyamines with ion channels. , 1997, The Biochemical journal.

[66]  E. Nestler,et al.  A molecular and cellular theory of depression. , 1997, Archives of general psychiatry.

[67]  C. Katona,et al.  Dopamine D1 and D2 receptor binding sites in brain samples from depressed suicides and controls , 1997, Brain Research.

[68]  J. Soares,et al.  The anatomy of mood disorders—review of structural neuroimaging studies , 1997, Biological Psychiatry.

[69]  Ronald W. Davis,et al.  Quantitative Monitoring of Gene Expression Patterns with a Complementary DNA Microarray , 1995, Science.

[70]  G. Nowak,et al.  Alterations in the N-methyl-d-asparatate (NMDA) receptor complex in the frontal cortex of suicide victims , 1995, Brain Research.

[71]  T. Teyler,et al.  Spermine depresses NMDA, K/AMPA and GABAA-mediated synaptic transmission in the rat hippocampal slice preparation , 1994, Brain Research.

[72]  L. Simard,et al.  Linkage disequilibrium analysis of childhood-onset spinal muscular atrophy (SMA) in the French-Canadian population. , 1994, Human molecular genetics.

[73]  V. Arango,et al.  Quantitative autoradiography of α 1- and α 2-adrenergic receptors in the cerebral cortex of controls and suicide victims , 1993, Brain Research.

[74]  C. Katona,et al.  NMDA glutamatergic receptors, labelled with [3H]MK-801, in brain samples from drug-free depressed suicides , 1993, Brain Research.

[75]  H. Manji.  G proteins: implications for psychiatry. , 1992, The American journal of psychiatry.

[76]  J. García-Sevilla,et al.  α 2-Adrenoceptors in the brain of suicide victims: increased receptor density associated with major depression , 1992, Biological Psychiatry.

[77]  K. Williams,et al.  Polyamines Modulate the Binding of [3H]MK‐801 to the Solubilized N‐Methyl‐D‐Aspartate Receptor , 1991, Journal of neurochemistry.

[78]  L. Hankoff.  Suicide Over the Life Cycle: Risk Factors, Assessment, and Treatment of Suicidal Patients , 1991 .

[79]  T. Goldberg,et al.  The hippocampus and parahippocampus in schizophrenia, suicide, and control brains. , 1990, Archives of general psychiatry.

[80]  D. Pickar,et al.  Suicidal behavior in depression: Relationship to noradrenergic function , 1989, Biological Psychiatry.

[81]  C. Katona,et al.  Brain GABAA/benzodiazepine binding sites and glutamic acid decarboxylase activity in depressed suicide victims , 1988, Brain Research.

[82]  B. Seizinger,et al.  Differential effects of acute and chronic ethanol treatment on particular opioid peptide systems in discrete regions of rat brain and pituitary , 1983, Pharmacology Biochemistry and Behavior.

[83]  R. S. Stacey,et al.  5-hydroxytryptamine, noradrenaline, and dopamine in brainstem, hypothalamus, and caudate nucleus of controls and of patients committing suicide by coal-gas poisoning. , 1969, Lancet.

[84]  J. Davis,et al.  Noradrenaline, 5-hydroxytryptamine, and 5-hydroxyindoleacetic acid in hindbrains of suicidal patients. , 1968, Lancet.

[85]  J. Mellerio,et al.  The Compulsive Gambler , 1964, British medical journal.

[86]  Fuad G. Gwadry,et al.  Implication of SSAT by gene expression and genetic variation in suicide and major depression. , 2006, Archives of general psychiatry.

[87]  Yogesh K. Dwivedi,et al.  ERK MAP kinase signaling in post-mortem brain of suicide subjects: differential regulation of upstream Raf kinases Raf-1 and B-Raf , 2006, Molecular Psychiatry.

[88]  D. Allison,et al.  Microarray data analysis: from disarray to consolidation and consensus , 2006, Nature Reviews Genetics.

[89]  J. Cryan,et al.  Don't worry 'B' happy!: a role for GABA(B) receptors in anxiety and depression. , 2005, Trends in pharmacological sciences.

[90]  T. Duka,et al.  Acute and chronic ethanol treatment changes endorphin levels in brain and pituitary , 2004, Psychopharmacology.

[91]  P. Escribá,et al.  Increased mRNA expression of alpha2A-adrenoceptors, serotonin receptors and mu-opioid receptors in the brains of suicide victims. , 2004, Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology.

[92]  Robert Tibshirani,et al.  Statistical methods for identifying differentially expressed genes in DNA microarrays. , 2003, Methods in molecular biology.

[93]  O. Petroff,et al.  GABA and glutamate in the human brain. , 2002, The Neuroscientist : a review journal bringing neurobiology, neurology and psychiatry.

[94]  C. Nemeroff,et al.  Recent advances in the neurobiology of depression. , 2002, Psychopharmacology bulletin.

[95]  R. Lewis,et al.  Spermine modulation of the glutamate(NMDA) receptor is differentially responsive to conantokins in normal and Alzheimer's disease human cerebral cortex. , 2002, Journal of neurochemistry.

[96]  L. Staib,et al.  Hippocampal volume reduction in major depression. , 2000, The American journal of psychiatry.

[97]  W. Drevets.  Functional anatomical abnormalities in limbic and prefrontal cortical structures in major depression. , 2000, Progress in brain research.

[98]  Health systems: improving performance , 2000 .

[99]  W. Drevets,et al.  Functional neuroimaging studies of depression: the anatomy of melancholia. , 1998, Annual review of medicine.

[100]  D. Lockhart,et al.  Expression monitoring by hybridization to high-density oligonucleotide arrays , 1996, Nature Biotechnology.

[101]  Y. Benjamini,et al.  Controlling the false discovery rate: a practical and powerful approach to multiple testing , 1995 .

[102]  V. Arango,et al.  Quantitative autoradiography of alpha 1- and alpha 2-adrenergic receptors in the cerebral cortex of controls and suicide victims. , 1993, Brain research.

[103]  J. García-Sevilla,et al.  Increased alpha 2-adrenoceptor density in the frontal cortex of depressed suicide victims. , 1987, Journal of neural transmission.

[104]  Stephen J. DeArmond,et al.  Structure of the human brain : a photographic atlas , 1974 .

[105]  L. Peltonen,et al.  LOW PREVALENCE OF HUNTINGTONS-DISEASE IN FINLAND , 1900 .